COSMOS Pharmaceutical Corporation (CSMYF)
USD 46.06
(0.0%)
USD 46.06
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 964.98 Billion JPY | 16.59% |
| 2023 | 827.69 Billion JPY | 9.57% |
| 2022 | 755.41 Billion JPY | 3.99% |
| 2021 | 726.42 Billion JPY | 6.14% |
| 2020 | 684.4 Billion JPY | 11.99% |
| 2019 | 611.13 Billion JPY | 9.52% |
| 2018 | 557.99 Billion JPY | 10.99% |
| 2017 | 502.73 Billion JPY | 12.4% |
| 2016 | 447.27 Billion JPY | 9.5% |
| 2015 | 408.46 Billion JPY | 9.85% |
| 2014 | 371.82 Billion JPY | 12.91% |
| 2013 | 329.31 Billion JPY | 18.02% |
| 2012 | 279.02 Billion JPY | 17.64% |
| 2011 | 237.17 Billion JPY | 15.48% |
| 2010 | 205.38 Billion JPY | 15.54% |
| 2009 | 177.75 Billion JPY | 19.91% |
| 2008 | 148.24 Billion JPY | 17.8% |
| 2007 | 125.84 Billion JPY | 19.8% |
| 2006 | 105.04 Billion JPY | 33.56% |
| 2005 | 78.65 Billion JPY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 FY | 964.98 Billion JPY | 16.59% |
| 2024 Q4 | 249.67 Billion JPY | 4.52% |
| 2024 Q3 | 238.88 Billion JPY | 1.75% |
| 2024 Q1 | 241.65 Billion JPY | 9.15% |
| 2024 Q2 | 234.77 Billion JPY | -2.85% |
| 2023 FY | 827.69 Billion JPY | 9.57% |
| 2023 Q2 | 197.89 Billion JPY | -3.99% |
| 2023 Q3 | 202.28 Billion JPY | 2.22% |
| 2023 Q4 | 221.39 Billion JPY | 9.45% |
| 2023 Q1 | 206.12 Billion JPY | 4.88% |
| 2022 Q3 | 187.74 Billion JPY | 3.31% |
| 2022 FY | 755.41 Billion JPY | 3.99% |
| 2022 Q4 | 196.52 Billion JPY | 4.68% |
| 2022 Q2 | 181.72 Billion JPY | -4.05% |
| 2022 Q1 | 189.4 Billion JPY | 2.53% |
| 2021 Q1 | 189.16 Billion JPY | -1.23% |
| 2021 Q2 | 175.01 Billion JPY | -7.48% |
| 2021 Q4 | 184.72 Billion JPY | 4.06% |
| 2021 Q3 | 177.52 Billion JPY | 1.43% |
| 2021 FY | 726.42 Billion JPY | 6.14% |
| 2020 Q1 | 164.5 Billion JPY | 2.4% |
| 2020 Q4 | 191.52 Billion JPY | 14.27% |
| 2020 FY | 684.4 Billion JPY | 11.99% |
| 2020 Q3 | 167.6 Billion JPY | 4.25% |
| 2020 Q2 | 160.76 Billion JPY | -2.27% |
| 2019 FY | 611.13 Billion JPY | 9.52% |
| 2019 Q3 | 152.11 Billion JPY | 5.02% |
| 2019 Q4 | 160.65 Billion JPY | 5.61% |
| 2019 Q1 | 153.53 Billion JPY | 4.28% |
| 2019 Q2 | 144.83 Billion JPY | -5.66% |
| 2018 Q2 | 132.1 Billion JPY | -4.77% |
| 2018 FY | 557.99 Billion JPY | 10.99% |
| 2018 Q4 | 147.22 Billion JPY | 5.21% |
| 2018 Q3 | 139.93 Billion JPY | 5.92% |
| 2018 Q1 | 138.72 Billion JPY | 4.96% |
| 2017 Q1 | 126.57 Billion JPY | 5.95% |
| 2017 Q4 | 132.16 Billion JPY | 7.0% |
| 2017 FY | 502.73 Billion JPY | 12.4% |
| 2017 Q2 | 120.46 Billion JPY | -4.83% |
| 2017 Q3 | 123.52 Billion JPY | 2.54% |
| 2016 Q2 | 106.24 Billion JPY | -3.71% |
| 2016 FY | 447.27 Billion JPY | 9.5% |
| 2016 Q3 | 111.22 Billion JPY | 4.69% |
| 2016 Q1 | 110.33 Billion JPY | 4.56% |
| 2016 Q4 | 119.47 Billion JPY | 7.41% |
| 2015 FY | 408.46 Billion JPY | 9.85% |
| 2015 Q1 | 104.75 Billion JPY | 5.02% |
| 2015 Q2 | 96.47 Billion JPY | -7.91% |
| 2015 Q3 | 101.71 Billion JPY | 5.43% |
| 2015 Q4 | 105.52 Billion JPY | 3.75% |
| 2014 Q1 | 93.75 Billion JPY | 6.44% |
| 2014 FY | 371.82 Billion JPY | 12.91% |
| 2014 Q4 | 99.74 Billion JPY | 8.95% |
| 2014 Q3 | 91.55 Billion JPY | 5.51% |
| 2014 Q2 | 86.76 Billion JPY | -7.45% |
| 2013 Q4 | 88.08 Billion JPY | 8.27% |
| 2013 FY | 329.31 Billion JPY | 18.02% |
| 2013 Q1 | 82.22 Billion JPY | 7.77% |
| 2013 Q2 | 77.64 Billion JPY | -5.57% |
| 2013 Q3 | 81.35 Billion JPY | 4.78% |
| 2012 Q1 | 68.53 Billion JPY | 7.99% |
| 2012 FY | 279.02 Billion JPY | 17.64% |
| 2012 Q3 | 69.11 Billion JPY | 6.19% |
| 2012 Q2 | 65.08 Billion JPY | -5.04% |
| 2012 Q4 | 76.29 Billion JPY | 10.39% |
| 2011 FY | 237.17 Billion JPY | 15.48% |
| 2011 Q4 | 63.46 Billion JPY | 9.07% |
| 2011 Q1 | 59.45 Billion JPY | 10.42% |
| 2011 Q2 | 56.07 Billion JPY | -5.69% |
| 2011 Q3 | 58.18 Billion JPY | 3.77% |
| 2010 Q2 | 50.26 Billion JPY | -2.49% |
| 2010 Q1 | 51.54 Billion JPY | 6.14% |
| 2010 Q4 | 53.84 Billion JPY | 8.26% |
| 2010 FY | 205.38 Billion JPY | 15.54% |
| 2010 Q3 | 49.73 Billion JPY | -1.06% |
| 2009 Q2 | 41.57 Billion JPY | 0.0% |
| 2009 Q4 | 48.56 Billion JPY | 9.16% |
| 2009 FY | 177.75 Billion JPY | 19.91% |
| 2009 Q3 | 44.49 Billion JPY | 7.01% |
| 2008 FY | 148.24 Billion JPY | 17.8% |
| 2007 FY | 125.84 Billion JPY | 19.8% |
| 2006 FY | 105.04 Billion JPY | 33.56% |
| 2005 FY | 78.65 Billion JPY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Alternative Energy Partners, Inc. | - USD | -Infinity% |
| Allstar Health Brands, Inc. | - USD | -Infinity% |
| Beijing Tong Ren Tang Chinese Medicine Company Limited | 195.23 Million USD | -494161.107% |
| Café Serendipity Holdings, Inc. | 44.55 Thousand USD | -2165837628.65% |
| Decision Diagnostics Corp. | - USD | -Infinity% |
| Health Advance Inc. | - USD | -Infinity% |
| HealthWarehouse.com, Inc. | 20.28 Million USD | -4757445.8% |
| LIGAND PHARMACEUTICAL INC | 131.31 Million USD | -734771.377% |
| MedGen, Inc. | 1.05 USD | -91903714285614.286% |
| Omni Health, Inc. | 4.69 Million USD | -20552168.102% |
| Oxford Investments Holdings Inc. | 61.16 Thousand USD | -1577629994.659% |
| Pineapple, Inc. | 381.89 Thousand USD | -252687584.935% |
| ScripsAmerica, Inc. | 30.85 Million USD | -3127431.223% |